EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Isohemagglutinin titration in pooled and apheresis platelets

QingYun Hua iD, Bruce W Lyon, Jennifer Duke, Amanda Felske, Karen Hobbs, Ryan Holman, Ghazala Radwi, Davinder Sidhu, Gwen Clarke, Susan Nahirniak

Transfusion · 2024

DOI: 10.1111/trf.17873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von QingYun Hua und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Platelet Transfusion, ABO Blood-Group System, Blood Platelets, Plateletpheresis. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Platelet inventory constraints necessitate ABO‐incompatible platelet transfusion. Many minimize the hemolytic impact by confirming low titre (LT) donor isohemagglutinins. This process is costly. Pathogen‐reduced platelets (PRP) in platelet additive solutions (PAS) will dilute plasma and decrease high‐titre isohemagglutinins (HT). We determined the proportion of HT platelets and incompatible transfusions for units suspended in plasma to reassess the need for titres following introduction of PRP/PAS. Study Design and Methods Our titre method is manual tube (1:50) dilution of platelet supernatant from apheresis or whole blood derived buffy coat pools suspended in plasma, tested with A1/B red cells. Testing included 49,058 pooled and 11,738 apheresis platelets over 4 years. The HT proportion, rate of out‐of‐group transfusions, and hemolytic reactions were determined. The impact of PAS dilution was estimated.

Results

Totally 60,796 platelet units were tested. Group O pooled and group B apheresis platelets had HT in 6.6% and 5.7%, respectively. Group A pooled and apheresis platelets included 2% with HT. Approximately 25% of platelets transfused were ABO‐incompatible and no hemolytic reactions were reported. Based on the proportions of PAS‐E and plasma for PRP platelets, plasma from each donor comprises 11 mL (6% of total volume) vs 20‐257 mL in untreated pools. PAS‐E will replace and dilute residual plasma by at least 50%.

Discussion

Rare platelet pools may demonstrate HT. PRP platelets with PAS will reduce titres and may abrogate the need for titration. A strategy of group specific transfusion or transfusion of group A PRP platelet transfusions may be a safe alternative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet TransfusionABO Blood-Group SystemBlood PlateletsPlateletpheresisHumansBlood Group IncompatibilityHemagglutinins

Stichwörter der Autor:innen

blood component preparationsimmunology (other than RBC serology)platelet transfusion

Substanzen

ABO Blood-Group SystemHemagglutinins

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Transfusion & Transplantation Medicine Program, Alberta Precision Laboratories, Edmonton, Alberta, Canada.

ORCID-Profile: QingYun Hua

Zitieren

APA

Hua, Q., Lyon, B. W., Duke, J., Felske, A., Hobbs, K., Holman, R., Radwi, G., Sidhu, D., Clarke, G., & Nahirniak, S. (2024). Isohemagglutinin titration in pooled and apheresis platelets. Transfusion. https://doi.org/10.1111/trf.17873

Vancouver

Hua Q, Lyon BW, Duke J, Felske A, Hobbs K, Holman R, et al. Isohemagglutinin titration in pooled and apheresis platelets. Transfusion. 2024. doi:10.1111/trf.17873

BibTeX
@article{Hua2024,
  author = {Hua, QingYun and Lyon, Bruce W and Duke, Jennifer and Felske, Amanda and Hobbs, Karen and Holman, Ryan and Radwi, Ghazala and Sidhu, Davinder and Clarke, Gwen and Nahirniak, Susan},
  title = {Isohemagglutinin titration in pooled and apheresis platelets},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17873}
}
Kostenlos starten →